Adult Acute Myeloblastic Leukemia

1 clinical trials · Condition

Record	Firm	Date
Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML) (NCT00890929)	Stanford University	2009-04-01

Every clearance here is in the API, with alerts when new ones post.